OC4. Number and sites of bone lesions and history of skeletal-related events (SREs): Do these parameters correspond with skeletal morbidity and mortality in patients with bone metastases (mets) from hormone-refractory prostate cancer (HRPC)?
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- 2008
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Cancer Treatment Reviews Journal